Audentes Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Audentes Therapeutics, Inc.
CIK #0001628738
EDGAR Form CIK 2011 - 2025
10-K [0001628738]
10-Q [0001628738]
3 [0001628738]
4 [0001628738]
8-K [0001628738]
D [0001628738]
SC 13D [0001628738]
SC 13G [0001628738]
Form 13D/13G Filer Form 13D/13G Subject Filed
Audentes Therapeutics Inc Taysha Gene Therapies Inc [2022-10-31]
Vanguard Group Inc Audentes Therapeutics Inc [2020-02-11]
Great Point Partners LLC Audentes Therapeutics Inc [2019-09-16]
Redmile Group LLC Audentes Therapeutics Inc [2019-02-14]
BlackRock Inc Audentes Therapeutics Inc [2019-02-08]
Partner Fund Management LP Audentes Therapeutics Inc [2018-10-29]
Price T Rowe Associates Inc /MD/ Audentes Therapeutics Inc [2018-02-14]
Wellington Management Group LLP Audentes Therapeutics Inc [2018-02-12]
FMR LLC Audentes Therapeutics Inc [2017-10-10]
Adage Capital Partners GP LLC Audentes Therapeutics Inc [2017-04-27]
5AM Ventures III LP Audentes Therapeutics Inc [2017-02-14]
Versant Side Fund IV LP Audentes Therapeutics Inc [2017-02-14]
OrbiMed Capital GP IV LLC Audentes Therapeutics Inc [2017-02-13]
Sofinnova Venture Partners IX LP Audentes Therapeutics Inc [2016-07-27]
Flynn James E Audentes Therapeutics Inc [2016-07-25]
Form 3/4/5 Subject 2011 - 2025
Taysha Gene Therapies, Inc.
Astellas Pharma Inc.
Audentes Therapeutics, Inc.
Soloway Thomas P
Smith Julie
Schuetz Thomas J.
Patterson Matthew R
Mosbrooker Eric
Morrison Scott W
Meltz Mark A
View All
Terms | Privacy | Guide
tony@aum13f.com